Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy

Various immunotherapeutic agents that can elicit antitumor immune responses have recently been developed with the potential for improved efficacy in treating cancer. However, insufficient delivery efficiency at the tumor site, along with severe side effects after systemic administration of these ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeongrae, Choi, Yongwhan, Kim, Dong-Hwee, Yoon, Hong Yeol, Kim, Kwangmeyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502377/
https://www.ncbi.nlm.nih.gov/pubmed/36145656
http://dx.doi.org/10.3390/pharmaceutics14091908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502377/
https://www.ncbi.nlm.nih.gov/pubmed/36145656
http://dx.doi.org/10.3390/pharmaceutics14091908

Ejemplares similares